동물용 진정제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 유형별, 투여 경로별, 지역별, 경쟁별(2020-2030년)
Animal Sedative Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Route of Administration, By Region and Competition, 2020-2030F
상품코드:1667926
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
동물용 진정제 세계 시장 규모는 2024년 1억 3,204만 달러로 평가되었고, 예측 기간 동안 4.65%의 연평균 복합 성장률(CAGR)로 2030년에는 1억 7,386만 달러에 달할 것으로 예상됩니다.
동물용 진정제 시장은 코로나19 팬데믹의 초기 단계에서 눈에 띄는 혼란을 겪었습니다. 이는 주로 세계 각국 정부가 봉쇄 및 사회적 거리두기와 같은 봉쇄 조치를 대대적으로 시행하면서 동물병원과 약국의 업무가 크게 축소되었기 때문입니다. 예를 들어, Faunalytics가 2022년 12월에 실시한 조사에 따르면, 미국과 캐나다의 약 70%의 동물병원이 전염병 확산 방지를 위해 일반 진료를 일시적으로 중단하고 동물이 보호자나 보호자 없이 예약 진료를 받아야 하는 상황에 처한 것으로 나타났습니다. 되었습니다.
Global Animal Sedative Market was valued at USD 132.04 Million in 2024 and is expected to reach USD 173.86 Million by 2030 with a CAGR of 4.65% during the forecast period. The animal sedative market saw a notable disruption during the initial phase of the COVID-19 pandemic. This was primarily due to the extensive implementation of containment measures like lockdowns and social distancing by governments worldwide, which significantly reduced the operations of veterinary hospitals and pharmacies. For instance, a study conducted by Faunalytics in December 2022 revealed that in order to prevent disease transmission during the pandemic, approximately 70% of clinics in the United States and Canada temporarily suspended public access, leading to situations where animals had to attend appointments without their owners or guardians.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 132.04 Million
Market Size 2030
USD 173.86 Million
CAGR 2025-2030
4.65%
Fastest Growing Segment
Parenteral
Largest Market
North America
Key Market Drivers
Increasing Pet Ownership
Pet ownership has become a global phenomenon, with millions of households worldwide welcoming furry, feathered, or scaly companions into their lives. This surge in pet ownership is not just about companionship; it's also driving growth in various industries, including veterinary care and pharmaceuticals.
As more people open their homes to pets, there is a growing emphasis on pet healthcare. Pet owners are increasingly recognizing the importance of regular veterinary check-ups, vaccinations, and surgical procedures when needed. For these medical interventions, sedation is often required to ensure the safety and comfort of the animals. In May 2023, Virbac acquired GS Partners, its long-term distributor in the Czech Republic and Slovakia, marking its 35th subsidiary and strengthening its position in Central Europe. This acquisition aims to boost Virbac's capacity to address the animal health needs in the region, particularly focusing on the pet and ruminant sectors.
Key Market Challenges
Ethical Concerns
Ethical concerns surrounding animal testing are a growing issue in the veterinary and pharmaceutical industries, raising questions about the morality and necessity of using animals for testing purposes. The use of animals to test the safety and efficacy of new sedatives, vaccines, and other treatments presents a delicate balance between ensuring product effectiveness and minimizing harm to animals. As consumers and regulatory bodies place increasing importance on animal welfare, companies in the industry are under pressure to adopt more humane practices. Many organizations are prioritizing the reduction of animal testing through the development and implementation of alternative testing methods, such as in vitro models, organ-on-a-chip technologies, and computer simulations. These advancements offer potential solutions to alleviate the ethical burden by providing more reliable, humane alternatives. Nonetheless, it is still an ongoing challenge to ensure that these alternatives meet the rigorous standards required for veterinary treatments while still maintaining the highest level of animal welfare possible.
Key Market Trends
Advancements in Sedative Formulations
Recent innovations in pharmaceutical research have led to the development of more effective, safer, and faster-acting sedatives for veterinary use. These advancements are revolutionizing the way sedation is administered in animals, improving the quality of care and reducing the risks associated with traditional sedatives. New formulations are designed to not only act more quickly but also to minimize side effects, such as post-sedation confusion or extended recovery times, which can sometimes occur with older sedative agents. These newer sedatives often provide better control over the depth and duration of sedation, allowing veterinarians to perform procedures with greater precision and confidence. In November 2022, SeQuent Scientific Limited (SeQuent), a prominent Indian company specializing in animal health products, particularly veterinary formulations and APIs, entered into a binding agreement to purchase the entire ownership stake, equivalent to 100%, in Tineta Pharma Private Limited (Tineta), an Indian-based company.
Additionally, many of these advanced formulations are designed with a lower risk of adverse reactions, reducing the likelihood of complications during or after the procedure. This ensures a safer overall experience for the animal, leading to quicker recovery times and less stress on both the animal and the veterinary team. The continued research and development in sedative formulations are making veterinary procedures more efficient, safer, and more comfortable for animals, improving both clinical outcomes and the overall experience for veterinary professionals.
Key Market Players
Zoetis Inc
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Elanco Animal Health Inc
Virbac S.A.
Dechra Pharmaceuticals Limited
Orion Corporation
Vetoquinol SA
Bimeda, Inc.
Chanelle Pharma Group
Report Scope:
In this report, the Global Animal Sedative Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Animal Sedative Market, By Type:
Acepromazine
Butorphanol
Detomidine
Romifidine
Xylazine
Animal Sedative Market, By Route of Administration:
Oral
Parenteral
Animal Sedative Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Animal Sedative Market.
Available Customizations:
Global Animal Sedative market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Animal Sedative Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
5.2.2. By Route of Administration (Oral, Parenteral)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Animal Sedative Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Route Of Administration
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Animal Sedative Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Route Of Administration
6.3.2. Canada Animal Sedative Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Route Of Administration
6.3.3. Mexico Animal Sedative Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Route Of Administration
7. Europe Animal Sedative Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Route Of Administration
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Animal Sedative Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Route Of Administration
7.3.2. United Kingdom Animal Sedative Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Route Of Administration
7.3.3. Italy Animal Sedative Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Route Of Administration
7.3.4. France Animal Sedative Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Route Of Administration
7.3.5. Spain Animal Sedative Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Route Of Administration
8. Asia-Pacific Animal Sedative Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Route Of Administration
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Animal Sedative Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Route Of Administration
8.3.2. India Animal Sedative Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Route Of Administration
8.3.3. Japan Animal Sedative Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Route Of Administration
8.3.4. South Korea Animal Sedative Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Route Of Administration
8.3.5. Australia Animal Sedative Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Route Of Administration
9. South America Animal Sedative Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Route Of Administration
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Animal Sedative Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Route Of Administration
9.3.2. Argentina Animal Sedative Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Route Of Administration
9.3.3. Colombia Animal Sedative Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Route Of Administration
10. Middle East and Africa Animal Sedative Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Route Of Administration
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Animal Sedative Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Route Of Administration
10.3.2. Saudi Arabia Animal Sedative Market Outlook
